Long-term Local Control Following CEA-targeted Fluorescence-guided Surgery in Patients With Locally Advanced and Recurrent Rectal Cancer.

Saved in:
Bibliographic Details
Title: Long-term Local Control Following CEA-targeted Fluorescence-guided Surgery in Patients With Locally Advanced and Recurrent Rectal Cancer.
Authors: Warmerdam MI; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands. m.i.warmerdam@lumc.nl., Creemers DMJ; Department of Surgery, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.; Department of GROW, School for Developmental Biology & Oncology, Maastricht University, Maastricht, the Netherlands., Kusters M; Department of Surgery, Amsterdam University Medical Center (AUMC), Amsterdam, The Netherlands., Peeters KCMJ; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Holman FA; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Mieog JSD; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Cailler F; Surgimab, Montpellier, France., Burger PJWA; Department of Surgery, Catharina Hospital Eindhoven, Eindhoven, The Netherlands., Burggraaf J; Center for Human Drug Research (CHDR), Leiden, The Netherlands., Rutten HJT; Department of Surgery, Catharina Hospital Eindhoven, Eindhoven, The Netherlands.; Department of GROW, School for Developmental Biology & Oncology, Maastricht University, Maastricht, the Netherlands., Verhoef C; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam University Medical Center, Rotterdam, The Netherlands., Vahrmeijer AL; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., Hilling DE; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands.; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam University Medical Center, Rotterdam, The Netherlands.
Source: Molecular imaging and biology [Mol Imaging Biol] 2025 Aug; Vol. 27 (4), pp. 629-637. Date of Electronic Publication: 2025 Jun 05.
Publication Type: Journal Article; Clinical Trial, Phase II
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101125610 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1860-2002 (Electronic) Linking ISSN: 15361632 NLM ISO Abbreviation: Mol Imaging Biol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1860-2002
DOI:10.1007/s11307-025-02021-4